Antipsychotic polypharmacy: review of mechanisms, mortality and management

Langan, J. and Shajahan, P. (2010) Antipsychotic polypharmacy: review of mechanisms, mortality and management. Psychiatrist, 34(2), pp. 58-62. (doi:10.1192/pb.bp.108.024257)

Langan, J. and Shajahan, P. (2010) Antipsychotic polypharmacy: review of mechanisms, mortality and management. Psychiatrist, 34(2), pp. 58-62. (doi:10.1192/pb.bp.108.024257)

Full text not currently available from Enlighten.

Abstract

Antipsychotic polypharmacy is an increasingly encountered clinical scenario. This review considers the reasons behind antipsychotic polypharmacy and the patterns of its use. We also consider the evidence of effectiveness of combined therapy v. monotherapy and the rationale behind the potentially beneficial combinations that are used. The potential dangers of antipsychotic polypharmacy are also discussed and the limited research regarding switching from polypharmacy to monotherapy is reviewed. Some provisional recommendations regarding antipsychotic polypharmacy are proposed.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Langan-Martin, Dr Julie
Authors: Langan, J., and Shajahan, P.
College/School:College of Medical Veterinary and Life Sciences > Institute of Health and Wellbeing > Mental Health and Wellbeing
Journal Name:Psychiatrist
ISSN:1758-3209
ISSN (Online):1758-3217

University Staff: Request a correction | Enlighten Editors: Update this record